The requirement for extensive capital investment and complex infrastructure for in-house filling of biologics has prompted biopharmaceutical companies to leverage the expertise of service providers for fill / finish of biologics LONDON, Sept. 12, 2023 /PRNewswire/ — Roots Analysis has…
NEW YORK, Sept. 12, 2023 /PRNewswire/ — TAFT, the trailblazing footwear brand renowned for its bold and distinct designs, is thrilled to unveil its latest endeavor, TAFT 365. Set for release on September 12th, TAFT 365 introduces a new benchmark in everyday footwear, seamlessly merging…
In anticipation of October’s Sudden Cardiac Arrest (SCA) Awareness Month, Contactor describes types of fainting, what fainting may signal about your heart health, and why you should seek medical attention directly after experiencing an episode to find out.
The most common type of syncope is vasovagal: fainting from a sudden drop in heart rate and blood pressure. Contractor describes a typical scenario: It is a hot day, you are dehydrated, and you’ve been standing for a long time. Suddenly, you feel nauseous, break out in a sweat, your face pales, a feeling of warmth envelops your body, and you gradually black out. In a few seconds, blood flow returns to your brain after being in a horizontal position, and you recover or wake up. After waking, you may feel exhausted.
When the brain senses that the heart is beating hard and blood pressure is high, Contractor says it sends an impulse throughout the body to relax. Blood stops reaching the brain during this maladaptive nervous system response, eventually making you faint.
Contractor warns to seek medical attention after any fainting episode, even if you suspect the cause was fatigue, heat, dehydration, or an emotional response.
“Sometimes a faint might seem vasovagal, but once you dive deeper, testing could reveal an underlying health concern,” Contractor says. “You want an expert to make this diagnosis and figure it out.”
If you experience this type of fainting frequently, Contractor says you will likely work with your care provider on lifestyle changes such as staying hydrated and wearing compression stockings. In some cases, he says you may wear a heart rhythm monitor to track your heart rate; based on the results, you and your physician will decide on the best treatment plan moving forward. For example, medications to raise blood pressure could help reduce fainting spells, Contractor says. In addition, a subset of patients could benefit from the implantation of a pacemaker, a small device placed in the chest to help control the heartbeat.
Other syncope scenarios that Contractor describes as “highly concerning” involve fainting out of the blue, without any symptoms (prodrome) during a period of inactivity — like sitting on the couch watching television — or in the midst of physical activity — like running across a basketball court and suddenly passing out.
These bouts of fainting may indicate the presence of cardiac arrhythmia, Contractor says. Arrhythmias occur when electrical impulses in the heart don’t work properly, causing an improper beating of the heart, whether irregular, too fast, or too slow. Arrhythmias are the most common cause of sudden cardiac arrest — the unexpected loss of heart function, breathing, and consciousness — according to the American Heart Association.
In these cases, Contractor says visiting the emergency department is the quickest way to obtain medical care. “You could faint again in a matter of minutes or hours,” he says. “You should be evaluated as soon as possible after the first episode, not five days later.”
The evaluation consists of testing via an electrocardiogram, an ultrasound of the heart, and possibly a heart rhythm monitor or coronary angiogram. Contractor says results from imaging will determine whether you need to undergo a cardiac MRI, receive an implantable cardioverter-defibrillator (ICD) to detect and stop irregular heartbeats, or obtain a pacemaker.
Someone who experiences this type of fainting may possess a slow heart rhythm that is malignant and requires a pacemaker, or they may be at risk for ventricular fibrillation — a life-threatening, fast heart rhythm from the heart’s bottom chamber. With ventricular fibrillation, the heart beats so fast that it doesn’t produce adequate blood flow to the brain. This type of arrhythmia is the most common one to cause cardiac arrest, Contractor says, and can cause irreversible brain damage and death.
“The bottom line is, don’t blow off a faint,” he says. “Seeing a doctor will help you understand the cause. You might rule out any heart problems, but even if a heart condition is found, you can take the right steps to ensure you’re safe from complications in the future.”
At Loma Linda University International Heart Institute, physicians are committed to providing patients with compassionate, comprehensive, and personalized cardiovascular care. To learn more, please visit lluh.org/heart-vascular. To schedule an interview with subject matter experts on this topic, please contact Lisa Aubry at [email protected].
Media Contact
Lisa Aubry, Loma Linda University Health, 9096515823, [email protected], news.llu.edu
For the past 50 years, NAC has been working to mitigate mental health, substance abuse, and housing crises in our community. Today, they own and operate four health service clinics and 19 housing sites in the greater Phoenix metropolitan area and are a member of the HUD Continuum of Care. NAC also operates the Phoenix Indian School Visitors Center where community programs and services are offered in addition to their health and housing services to more than 10,000 people each year.
In January 2023, the National Point-in-Time Unsheltered Street Count conducted by the Maricopa County Association of Governments found more than 10,000 people were experiencing homelessness in the Phoenix metropolitan area on a given night; 49% of who could be sheltered, more than 700 of whom were youth. Recognizing the growing youth homelessness crisis, NAC opened a second homeless youth shelter in Surprise. The new shelter accommodates 40 homeless youth between the ages of 18-26 years of age.
Funding from The Bob & Renee Parsons Foundation will support emergency shelter services for homeless youth at both the Central Phoenix and Surprise HomeBase sites. Those sites also provide medical and behavioral health assessments, counseling and support services, programs for homeless youth to earn their high school diplomas as well as training and career readiness programs. Additionally, the funds will support NAC’s transitional housing service site at Saguaro Ki, co-located on the Central Phoenix youth shelter campus. It is a 24- unit transitional housing community for youth ages 18-26, where they sign a lease, their monthly rent is 30% of their earned income, and they meet weekly with a case manager.
“Native American Connections is giving youth safety and stability now while teaching them life skills to attain stable housing in the future,” said Renee Parsons, co-founder of The Bob & Renee Parsons Foundation. “We applaud NAC’s efforts to empower youth to stay in school, improve their health and well-being, and become positive contributors to the greater community.”
About Native American Connections Native American Connections has been healing individuals, changing lives, and strengthening communities since 1972. We integrate Native American healing with evidence-based practices to support health and wellness, provide affordable housing, and champion community development projects. We are a leader in developing, building, and managing advanced behavioral health and state-of-the-art housing communities. NAC currently owns and operates 24 service sites throughout the greater Phoenix metro area and has three new sites, 1 health and 2 housing, planned to open in 2024-25. These health and housing services are open to all people.
About The Bob & Renee Parsons Foundation The Bob & Renee Parsons Foundation offers support to nonprofit organizations successfully working to empower, educate, nurture, and nourish people during what is often the darkest time of their lives. Founded in 2012 by philanthropists and business leaders Bob and Renee Parsons to provide hope and life-changing assistance to the country’s most vulnerable populations, The Bob & Renee Parsons Foundation offers critical funding at critical times to those in need. The Foundation’s giving is driven by the core belief that all people – regardless of race, religion, roots, economic status, sexual orientation, or gender identity – deserve access to quality healthcare, education, and a safe place to call home. Follow @WeDealInHope on social media or visit TBRPF.org, to learn more about partner organizations and the important work being done in the community.
Pioneer and visionary in robotics to help guide CytoVeris in driving their technology into robotic surgery applications
FARMINGTON, Conn., Sept. 12, 2023 /PRNewswire-PRWeb/ — CytoVeris Inc., a medical device company developing intraoperative tissue visualization technologies to improve surgical decision making, today announced that Dr. Fredric Moll, MD has joined the company as a Strategic Advisor to both the board and management team. Dr. Moll has a long history as a visionary in the field of surgical robotics and has founded several noteworthy companies, including surgical robotics company Auris Health, which was acquired by Johnson & Johnson in 2019. Dr. Moll joined J&J as Chief Development Officer as part of the acquisition.
Dr. Moll was a founder at Hansen Medical, Restoration Robotics, and Intuitive Surgical; the latter whose da Vinci system has made them the leader in robotic surgery. Prior to Intuitive, he was founder of Endotherapeutics, which was acquired by US Surgical, and Origin Medsystems, which was acquired by Eli Lily.
Dr. Moll holds an MD from the University of Washington School of Medicine, an MS in Management from Stanford University, and a B.A. from UC Berkeley. He is the author of numerous scientific articles and a frequent speaker at international conferences on robotics and MedTech.
In recent years, Dr. Moll has founded or co-founded several other medical device companies developing new innovative technologies. He currently serves on the boards of several healthcare companies including Moon Surgical, Procept BioRobotics, ShockWave Medical, RefleXion, and Avail Medsystems.
“We are thrilled that Dr. Moll will help guide CytoVeris’ development strategy for our AI-powered tissue imaging technology in minimally invasive surgery and robotic applications,” said Alan Kersey, CytoVeris’ President and CEO. “Fred is uniquely qualified to provide insight and guidance as we address the growing opportunity for enhanced tissue visualization in robotics. We see the application of robotics in surgery continuing to revolutionize healthcare. With the number of new entrants into the surgical robotics arena, the market is being significantly disrupted and surgeons and hospital administrators will look for advanced features in new offerings.”
About CytoVeris: Based in Farmington CT, CytoVeris is a medical device manufacturer developing AI-powered imaging technology for real-time ex-vivo tissue visualization and identification, enabling more precise intraoperative decisions, leading to improved patient outcomes and reducing unnecessary repeat procedures. Our intraoperative imaging platform, based on a proprietary Multi-Spectral Tissue Auto-Fluorescence Imaging (MS-TAFI) system and powered by AI-based algorithms, analyzes the “optical fingerprint” of the tissue corresponding to its intrinsic biomolecular and morphological characteristics, without the use of dyes or imaging agents.
Over a median follow-up period of 12.0 years, the cohort study recorded 1,182 lung cancer cases in women. According to the researchers, several reproductive factors showed a significant association with a higher risk of incident lung cancer among women. These factors included early menarche (age ≤ 11 years), early menopause (age ≤ 46 years or age of 47-49 years), a shorter reproductive span (age less than or equal to 32 years or age of 33-35 years), and early age at first birth (≤ 20 years or age of 21-25 years).
Stratified analysis revealed that some reproductive factors, especially early menopause, shortened reproductive span, and early age at first birth, displayed a substantially stronger association with elevated lung cancer risk, particularly non-small cell lung cancer (NSCLC), in populations with high genetic susceptibility and detrimental behaviors.
“These findings are of paramount importance in our understanding of the potential risk factors for lung cancer among women,” said the lead researcher, Dr. Y. Zhang from Xiangya Hospital, Central South University. “Early menarche, early menopause, and a shortened reproductive life span are associated with higher risks of incident lung cancer, especially NSCLC, in subpopulations with specific genetic risk and lifestyle choices.”
This pioneering research emphasizes the importance of screening multiple reproductive factors in identifying potential lung cancer risk among female populations. By understanding these associations, healthcare professionals can develop targeted preventive strategies and interventions to combat lung cancer effectively, Dr. Zhang reported.
About the IASLC:
The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association’s membership includes more than 8,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis, and treatment of all thoracic malignancies. Visit http://www.iaslc.org for more information.
About the WCLC:
The WCLC is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies, attracting more than 7,000 researchers, physicians, and specialists from more than 100 countries. The goal is to increase awareness, collaboration, and understanding of lung cancer, and to help participants implement the latest developments across the globe. The conference will cover a wide range of disciplines and unveil several research studies and clinical trial results. For more information, visit https://wclc2023.iaslc.org.
Concurrent photon-based chemoradiation is an established standard of care for unresectable locally advanced non-small cell lung cancer (NSCLC), However, the choice between IMRT and 3D-CRT has remained contentious due to limited prospective data. As IMRT is more labor-intensive and costlier than 3D-CRT, it is important to justify IMRT utilization based on long-term prospective outcomes.
The secondary analysis of NRG Oncology-RTOG 0617, spanning a median follow-up of 5.2 years, involved 482 patients with locally advanced NSCLC. Among them, 47% received IMRT and 53% received 3D-CRT. The study examined a range of parameters including 5-year overall survival (OS), progression-free survival (PFS), time to local failure (LF), distant metastasis-free survival (DMFS), adverse events, and the development of second malignancies.
Dr. Chun’s findings revealed that both IMRT and 3D-CRT groups exhibited similar OS, PFS, time to LF, and DMFS rates at the 5-year mark. Notably, IMRT was associated with a more than two-fold reduction in severe pneumonitis (3.5% vs. 8.2%) compared to 3D-CRT, demonstrating a clear advantage in reducing pulmonary toxicity.
Further analysis indicated a continuous association between heart V20-60Gy and survival, with heart V40Gy less than 20% linked to significantly improved survival rates. Multivariable analysis underscored the significance of heart V40Gy greater to or equal to 20% in predicting worse survival. In contrast, lung V5Gy did not significantly impact survival. Rates of second malignancy development were similar between IMRT and 3D-CRT groups.
Dr. Chun concluded that IMRT should be the preferred choice for locally advanced NSCLC to mitigate severe pulmonary toxicity and minimize radiation exposure to the heart. The study emphasized the importance of optimizing radiation planning, with special attention to reducing lung V20Gy and heart V20-60Gy, aiming for a heart V40Gy less than 20%. Encouragingly, the study did not find evidence that the low-dose bath (lung V5Gy) had a substantial impact on long-term survival or late severe toxicity.
These findings provide a crucial contribution to the ongoing discourse on radiation techniques for NSCLC treatment, paving the way for more informed clinical decisions and improved patient outcomes, according to Dr. Chun.
The study was supported by Eli Lily and Company and grants from the National Cancer Institute R50CA275822, U10CA180868, and U10CA180822.
About the IASLC: The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association’s membership includes more than 8,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis, and treatment of all thoracic malignancies. Visit http://www.iaslc.org for more information.
About the WCLC: The WCLC is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies, attracting more than 7,000 researchers, physicians, and specialists from more than 100 countries. The goal is to increase awareness, collaboration, and understanding of lung cancer, and to help participants implement the latest developments across the globe. The conference will cover a wide range of disciplines and unveil several research studies and clinical trial results. For more information, visit https://wclc2023.iaslc.org.
“Brian’s skill set is a great complement to our team, and his deep experience in white collar matters really solidifies our offering to that segment of the market,” said Proteus co-founder Jon Mattingly. “We’re well positioned to handle the unique workflows compared to traditional litigation discovery.”
“I have known the Proteus founders for over a decade, and I engaged them as an eDiscovery partner on multiple occasions. I’m thrilled to join the team and build on the ‘litigator-led’ perspective and culture that distinguishes Proteus from other providers,” said Weir-Harden.
Weir-Harden will also maintain an active litigation and white collar defense practice at
RED BANK, N.J., Sept. 12, 2023 /PRNewswire/ — New Standard Senior Living (NSSL), a New Jersey-based affordable, assisted living provider will host a Senior Health Fair on Wednesday, September 20, 2023 in the Egg Harbor Township assisted living community located at 6817 East Black Horse…
According to Board Certified pulmonologist, critical care physician, and co-chair of AMI’s Department of Medical Education, Anthony Santilli MD, “My personal experience is that physicians today are subjected to an unprecedented number of significant stressors, including overwork, cumbersome regulation, electronic medical records and coding requirements, medical liability, on-call issues, lack of sleep, politics, and frustrations with the reimbursement structure. By attending this conference and learning to practice Yoga Science as Mind/Body Medicine, healthcare professionals can definitely improve their job satisfaction and work/life balance, while reducing and preventing burnout symptoms of anger, depression, anxiety and exhaustion.”
The entire “Heart and Science of Yoga” CME curriculum is a transformative learning experience. It is dedicated to providing quality, comprehensive and evidence-based education. Other topics this year will include an encyclopedic overview and instruction on AMI Meditation, Epigenetics, diaphragmatic breathing, mantra science, yoga psychology, mind function optimization, Food as Medicine, Ayurveda, easy-gentle yoga, lymph system detoxification and detailed instruction on how to employ knowledge of the Chakra System as a practical and reliable diagnostic tool.
The dedication, enthusiasm, and teaching methodology of the entire AMI faculty create a dynamic and interactive course for their students. Each faculty member is committed to the advancement and training of Yoga Science as Holistic Mind/Body Medicine. In addition to faculty director Leonard Perlmutter other presenters include: Mark Pettus MD, board certified internist and nephrologist and Director of Medical Education and Population Health of Berkshire Health Systems; Kristin Kaelber MD, PhD, board certified in Internal Medicine and Pediatrics; Renee Rodriguez-Goodemote, MD, Medical Director of the Saratoga Hospital Community Health Center; Anthony Santilli MD, board certified in Pulmonary and Critical Care Medicine; Jesse Ritvo MD, Assistant Medical Director, Inpatient Psychiatry, University of Vermont Health Center; Joshua Zamer, MD, Medical Director for Addiction Medicine at Saratoga Hospital Community Health Center and Chairman of the Department of Family Practice; Gustavo Grodnitzky PhD, Chair of the AMI Psychological Education Committee; Jenness Cortez Perlmutter, co-founder and faculty member of The American Meditation Institute; Anita Burock-Stotts, MD, board certified in Internal Medicine; and Janine Pardo MD, board certified in Internal Medicine.
About the American Meditation Institute
The American Meditation Institute is a 501(c)3 non-profit educational organization devoted to the teaching and practice of Yoga Science, AMI Meditation® and its allied disciplines as Mind/Body Medicine. In its holistic approach to wellness, AMI combines the healing arts, philosophy and spirituality of the East with the practicality of modern Western medical science. The American Meditation Institute offers a wide variety of courses, conferences and webinars. AMI also publishes “[Transformation” a bi-monthly journal of Yoga Science as Holistic Mind/Body Medicine.
Call 518.674.8714 for interviews with AMI Founder Leonard Perlmutter or an email subscription to “Transformation.”
Media Contact: Robert Washington PO Box 430 Averill Park, NY 12018 Tel: 518-674-8714 Fax: 518-674-8714